TORONTO, June 21, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") announces that at its Annual Meeting of Shareholders held yesterday, June 20, 2024 (the "Meeting"), shareholders holding a total of 274,097,252 common shares of the Company voted in person or by proxy, representing 71.75% of the total number of common shares of the Company outstanding. Each of the directors listed as a nominee in the Company's definitive proxy statement dated April 26, 2024 was ...

TORONTO, June 21, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announces that at its Annual Meeting of Shareholders held yesterday, June 20, 2024 (the “Meeting”), shareholders holding a total of 274,097,252 common shares of the Company voted in person or by proxy, representing 71.75% of the total number of common shares of the Company outstanding. Each of the directors listed as a nominee in the Company’s definitive proxy statement dated April 26, 2024 wa ...

TORONTO, June 20, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company"), an innovative global cannabinoid company, announced an expansion of Cronos Growing Company ("GrowCo"). GrowCo is a leading cannabis cultivation company that Cronos owns 50% of. The investment will be funded by an additional credit facility provided by Cronos and is intended to assist GrowCo's expansion of its purpose-built cannabis facility to address the increased global market demand for high ...

文章核心观点 - 公司宣布对其子公司Cronos Growing Company(GrowCo)进行扩张投资 [1][2] - 此次投资旨在满足全球对优质大麻花的不断增长的需求 [1][2] - 此次投资将加强公司对GrowCo的管治权,并为公司带来更多的供应协议优势 [2][7] 关于GrowCo的总结 - GrowCo在2023年为公司贡献了约2100万美元的生物质采购,并向第三方销售约2000万美元 [3] - GrowCo拥有较高的毛利率,并在2023年实现了正净收益和正现金流 [3] - GrowCo具有规模化生产优质大麻的能力,满足公司的严格质量标准和市场需求 [3][4] 关于此次投资的总结 - 公司将提供约5100万美元的有担保的非循环信贷额度给GrowCo,用于扩建其现有的大麻种植设施 [5] - 该信贷额度的利率为加拿大最优惠利率加1.25%,GrowCo无需在新建设施投产前开始偿还本金 [5] - 公司将有权在新建设施投产前购买GrowCo约80%的产量,之后有权购买70%的年产量 [7] - 该扩建项目的完工和投产需要获得相关许可和批准 [8]

文章核心观点 - 当前股市处于看涨阶段,增长型股票和蓝筹股都有望出现广泛性上涨[1][2] - 宽松的货币政策将推动各类资产价格上涨,适合投资高风险的"迷因股"[2][3] 行业和公司总结 Bitfarms (BITF) - 比特币矿企Bitfarms被Riot Platforms提出2.3美元/股的收购报价,但Bitfarms拒绝了这一报价,表明BITF股票被低估[5] - Bitfarms拥有充沃的流动性缓冲,正计划大幅扩张算力产能,预计到2025年底达到35EH/s[6][7] - 随着比特币价格可能保持上涨趋势,Bitfarms未来24个月的收入和现金流有望大幅增长[7] Cronos (CRON) - 大麻可能被重新归类为III类药物,这将成为大麻股的重大催化剂,Cronos有望从中受益[9] - Cronos拥有8.55亿美元的强大现金储备,占其目前市值的95%,未来上涨空间巨大[10][11] - Cronos已进入德国、澳大利亚和英国等新市场,预计未来收入增长将加速[12] Joby Aviation (JOBY) - Joby Aviation的eVTOL飞行汽车预计将于2025年实现商业化[13] - Joby最近收购了Xwing的自主飞行技术部门,有望在自主技术方面获得优势,加快与美国国防部的合作[15] - Joby除了在美国的商业化,还与阿联酋和沙特阿拉伯达成了合作,2025年及以后的增长前景良好[16]

In a balanced portfolio, blue-chip stocks provide steady returns with the comfort of a low beta. On the other hand, growth stocks create big wealth. Today’s blue-chip companies started their journey as promising growth stocks and became millionaires on the way. This column focuses on growth stocks to buy and hold until the end of the decade for multibagger returns.I have said in the past and will emphasize again that identifying a potential value creator is not a big challenge. The real challenge is to buy ...

Sector and stock rotation is common in the world of investing. The hottest stocks of today are likely to be forgotten names of tomorrow. It's a good time to sell when the stock or sector is already overhyped. Similarly, looking at quality growth stocks to buy among the forgotten names that witnessed buying frenzy in the yesteryear is a good idea. After a period of price and time correction, the growth stocks discussed look attractive from a valuation perspective. Further, the business has navigated challeng ...

TORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company"), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at Bernstein's 40th Annual Strategic Decisions Conference on Thursday, May 30, 2024, at 2:30PM ET. A live webcast will be available on the Investors section of the Company's website at https://ir.thecronosgroup.com/events-presentations. About Cronos Group Inc.Cronos is an innov ...

TORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company"), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at Bernstein's 40th Annual Strategic Decisions Conference on Thursday, May 30, 2024, at 2:30PM ET. A live webcast will be available on the Investors section of the Company's website at https://ir.thecronosgroup.com/events-presentations. About Cronos Group Inc. Cronos is an in ...

TORONTO, May 28, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it has terminated its agreement (the “Sale Agreement”) with Future Farmco Canada Inc. (the “Buyer”), for the sale and leaseback of its property located at 4491 Concession 12 Sunnidale Road, Stayner, Ontario, Canada, L0M 1S0 (the “Peace Naturals Campus”). The Buyer did not satisfy or waive its due diligence and financing condition by the May 27, 2024 deadline, as set forth i ...